For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Screening Approach for the Separation of Pharmaceutical Compounds using Lux Polysaccharide-Based Chiral Stationary Phases in SFC Mode (TN-9004)
In this technical note, we present various SFC screening approaches for the chiral separation of a 56-pharmaceutical compound test set using Lux polysaccharide-based chiral stationary phases. The new Lux Amylose-1 provides the largest number of baseline separations. Additional generic chiral separation strategies for SFC are highlighted for increasing success rates.
Screening Approach for the Separation of Pharmaceutical Compounds using Lux Polysaccharide-Based Chiral Stationary Phases in SFC Mode (TN-9004)
In this technical note, we present various SFC screening approaches for the chiral separation of a 56-pharmaceutical compound test set using Lux polysaccharide-based chiral stationary phases. The new Lux Amylose-1 provides the largest number of baseline separations. Additional generic chiral separation strategies for SFC are highlighted for increasing success rates.
Document Type:
Technical Notes
Techniques:
Separation Modes:
Chiral